Imitrex

Rediff.com » News » Imitrex

News for Imitrex

Business

Dr Reddy's posts Rs 522-crore net loss

Dr Reddy's Laboratories, the country's second biggest drug maker, revealed an unexpected consolidated net loss of Rs 522 crore in the October-December quarter, due to a writedown of intangible......

Indian drug makers maintain pace of US mktg nod

Twenty five Indian generic drug makers got a little over 200 approvals from the US Food and Drug Administration in 2009, half a dozen more than the number approved in 2008. This increase is despite......

More laggards than winners in BSE-500 firms

An analysis of BSE-500 companies' second-quarter results shows that the picture is not as bright as it seemed initially. The profit of 1,731 companies studied by Business Standard rose over 35 per......

Indian generics profit from Glaxo patent expiry

GlaxoSmithKline Plc's anti-migraine drug brand, Imitrex, is turning out to be a good revenue earner for Indian generic companies, as the US Food and Drug Administration has given almost half of the......

Only 6 drug majors post better results

Only six of the top 25 drug companies, which include Dr Reddy's Lab, Sun Pharma and Zydus Cadila, could post better net profit in the December quarter in comparison to the corresponding previous......

Rediff News

Imitrex

News for Imitrex

Dr Reddy's posts Rs 522-crore net loss

Indian drug makers maintain pace of US mktg nod

More laggards than winners in BSE-500 firms

Indian generics profit from Glaxo patent expiry

Only 6 drug majors post better results

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS